Blavatnik Family Foundation to Provide $10 Million Grant for Immunobiology Research at Yale
Tuesday, April 09, 2013
Grant supports work of immunobiologists Ruslan Medzhitov and Richard Flavell.
Compugen Discloses Focused Target Discovery Program for ADC Cancer Therapy
Tuesday, April 09, 2013
Initial discoveries from new program anticipated before year-end.
Symposium Highlights Epigenetic Effects of Milk
Tuesday, April 09, 2013
It seems the ads were right. A milk mustache is a good thing to have. Animal and dairy scientists have discovered that drinking milk at an early age can help mammals throughout their lives.
Rockland Immunochemicals Acquires Epi-Plus® Product Line
Tuesday, April 09, 2013
Rockland Immunochemicals, Inc. announced the acquisition of the Epi-Plus® antibody product line from 21st Century Biochemicals, Inc.
Dako to Offer New Antibody in U.S. to Diagnose Breast Cancer
Monday, April 08, 2013
Dako receives clearance to sell FLEX Monoclonal Rabbit Anti-Human Estrogen Receptor a, Clone EP1 in US.
S-TARget Achieves In Vivo Proof of Concept for Its Allergy Vaccine SG100
Monday, April 08, 2013
SG100 is being developed for the prevention and therapy of severe allergic asthma caused by house dust mite (HDM) allergens.
Cellular Gatekeepers Do More than Open Doors for Drugs, UCSF Study Finds
Monday, April 08, 2013
Discovery could change the way we design medications and shed light on side effects.
Spirogen and BioAtla Present Positive Data on Next-Generation Warheads in ADCs Against Cancer
Monday, April 08, 2013
Data demonstrating excellent specificity presented at AACR.
Will Cell Therapy Become a 'Third Pillar' of Medicine?
Thursday, April 04, 2013
Treating patients with cells may one day become as common as it is now to treat the sick with drugs made from engineered proteins, antibodies or smaller chemicals.
|
|
|
|
|
|
